Tech Company Financing Transactions
Monopar Therapeutics Funding Round
Private investors participated in a $9.7 million venture round for Monopar Therapeutics. This venture round was announced by the company on 11/16/2017.
Transaction Overview
Company Name
Announced On
11/16/2017
Transaction Type
Venture Equity
Amount
$9,700,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1000 Skokie Blvd. 350
Wilmette, IL 60091
USA
Wilmette, IL 60091
USA
Phone
Website
Email Address
Overview
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing innovative drug combinations to improve clinical outcomes in advanced cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Christopher Starr
Chief Executive Officer
Chandler Robinson
Chief Financial Officer
Kim Tsuchimoto
Chief Medical Officer
Patrice Rioux
VP - R & D
Andrew Mazar
Browse more venture capital transactions:
Prev: 11/16/2017: Catalia Health venture capital transaction
Next: 11/16/2017: Inozyme Pharma venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs